Human Biology Division

Exploring Biological Systems to Find New Ways to Fight Cancer and Other Diseases

Grounded in high-quality science, researchers in the Human Biology Division perform fundamental, applied and translational research in model organisms and in vitro systems. With backgrounds in molecular and cell biology, genomics, genetics, virology, infectious disease, computational biology, pathology and clinical research, these investigators form an interdisciplinary team that in other institutions would likely be spread out over multiple departments. Together, they propel research toward new and improved approaches to the treatment and prevention of cancers and infectious diseases.

A group of research scientists.

Diverse Knowledge

Our faculty apply individual advances in human biology to their research into cancer and infectious diseases.

A research scientist dropping liquid into a petri dish.

Accelerating Advances

Our labs explore cancer and infectious diseases at a molecular and genetic level to discover new forms of treatment.

pull quote photo

“What drives me is making an impact in patients’ lives. Research is a continuous and intense process, not a short-term outcome.”

— Dr. Taran Gujral, cancer biologist

A Multidisciplinary Approach

Learn about our scientific leadership, job openings, upcoming events and seminars hosted by the Human Biology Research Team.

Latest Human Biology News

All Human Biology news
Finding a new way to break the supply chain fueling advanced prostate cancer Fred Hutch researcher wins a $1M grant for a London-Seattle collaboration to find new therapies for drug-resistant prostate cancer October 31, 2024
Bottleneck breakthrough Fred Hutch researchers discover why some HIV-1 variants are more transmissible than others, which could generate new approaches to stop the virus that causes AIDS at cell entry October 3, 2024
Making the most of a small supply Fred Hutch researchers receive $1.3 million grant from the U.S. Department of Defense to study the fundamental biology of five rare liver cancers that could lead to new treatments one day September 30, 2024